Advanced search
Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 49, 2020 - Issue 7: Thematic Issue: Micro and Nanoparticles in Immune Modulation. Guest Editor: Gautam N. Shenoy
Submit an article Journal homepage
226
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus

Gi-Ja Leea Department of Biomedical Engineering, College of Medicine, Kyung Hee University, Seoul, Republic of KoreaView further author information
,
Ki-Back Chub Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of KoreaView further author information
,
Kyung-Soo Innc Department of Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, Republic of KoreaView further author information
,
Eun-Kyung Moond Department of Medical Zoology, Kyung Hee University School of Medicine, Seoul, Republic of KoreaView further author information
&
Fu-Shi Quand Department of Medical Zoology, Kyung Hee University School of Medicine, Seoul, Republic of Korea;e Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA;f Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate school, Kyung Hee University, Seoul, Republic of KoreaCorrespondence[email protected]
View further author information
Pages 781-793 | Published online: 27 Nov 2019

References

  • Fritsch BF. 2009. FDA update on the H1N1 flu vaccine and antiviral medication. Food and Drug Administration; [accessed 2018 Dec 18]. https://www.fda.gov/downloads/forhealthprofessionals/ucm185724.pdf.
  • Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO. 2011. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza. Clin Vaccine Immunol. 18:2010–17.
  • Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW. 2001. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol. 166:7381–88.
  • Inn KS, Lee GJ, Quan FS. 2014. A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice. Immunol Invest. 43:236–54.
  • Jayasekera JP, Moseman EA, Carroll MC. 2007. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol. 81:3487–94.
  • Krammer F, Palese P, Steel J. 2015. Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr Top Microbiol. 386:301–21.
  • Lopez-Macias C. 2012. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vacc Immunother. 8:411–14.
  • Luo Y, Mohan T, Zhu W, Wang C, Deng L, Wang BZ. 2018. Sequential immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice. Sci Rep. 8:4577.
  • Moon EK, Kang HJ, Chu KB, Lee SH, Lee DH, Soh Y, Quan FS. 2019. Immune correlates of protection induced by virus-like particles containing 2009 H1N1 pandemic influenza HA, NA or M1 proteins. Immunol Invest. 48:355–66.
  • Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W. 2006. Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology. 352:418–26.
  • Quan FS, Compans RW, Cho YK, Kang SM. 2007a. Ginseng and salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine. 25:272–82.
  • Quan FS, Huang C, Compans RW, Kang SM. 2007b. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol. 81:3514–24.
  • Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW. 2011. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J Infect Dis. 204:987–95.
  • Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, Prausnitz MR, Compans RW, Kang SM. 2010a. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol. 84:7760–69.
  • Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang SM. 2008. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine. 26:3352–61.
  • Quan FS, Vunnava A, Compans RW, Kang SM. 2010b. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One. 5:e9161.
  • Quan FS, Yoo DG, Song JM, Clements JD, Compans RW, Kang SM. 2009. Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J Virol. 83:4489–97.
  • Ross TM, Mahmood K, Crevar CJ, Schneider-Ohrum K, Heaton PM, Bright RA. 2009. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS One. 4:e6032.
  • Schwartzman LM, Cathcart AL, Pujanauski LM, Qi L, Kash JC, Taubenberger JK. 2015. An intranasal virus-like particle vaccine broadly protects mice from multiple subtypes of influenza A virus. mBio. 6:e01044–15.
  • Tao P, Luo M, Zhu D, Qu S, Yang Z, Gao M, Guo D, Pan Z. 2009. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice. Viral Immunol. 22:273–81.
  • Yewdell JW. 2013. To dream the impossible dream: universal influenza vaccination. Curr Opin Virol. 3:316–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.